The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany
Clinical trial NCT03205722 · WITHDRAWN
Trial details
- NCT number
- NCT03205722
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-05
- Primary completion
- 2018-07-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.